EMRIS Pharma Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 5

EMRIS Pharma General Information

Description

Developer of a topical treatment intended to prevent skin toxicities caused by targeted cancer therapies. The company offers a first-in-class approach to block anti-cancer drugs at the toxicity site, improving patients' quality of life and therapy adherence without interfering with treatment and potentially enhancing well-being in cancer care, enabling clients to access improved cancer care and treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Wadi el-Haj Street13
  • Nazareth
  • Israel
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • Wadi el-Haj Street13
  • Nazareth
  • Israel

EMRIS Pharma Timeline

202420252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

EMRIS Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator 06-Mar-2024 Completed Generating Revenue
2. Seed Round 01-Aug-2023 Completed Generating Revenue
1. Spin-Off 08-Jun-2023 Completed Generating Revenue
To view EMRIS Pharma’s complete valuation and funding history, request access »

EMRIS Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

EMRIS Pharma Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
MassChallenge Accelerator/Incubator
Arieli Group Venture Capital Minority
Innovation Authority Government Minority
Hadasit Venture Capital Minority
NGT HealthCare II Venture Capital Minority
To view EMRIS Pharma’s complete investors history, request access »

EMRIS Pharma FAQs

  • When was EMRIS Pharma founded?

    EMRIS Pharma was founded in 2023.

  • Where is EMRIS Pharma headquartered?

    EMRIS Pharma is headquartered in Nazareth, Israel.

  • What is the size of EMRIS Pharma?

    EMRIS Pharma has 4 total employees.

  • What industry is EMRIS Pharma in?

    EMRIS Pharma’s primary industry is Drug Discovery.

  • Is EMRIS Pharma a private or public company?

    EMRIS Pharma is a Private company.

  • What is EMRIS Pharma’s current revenue?

    The current revenue for EMRIS Pharma is .

  • How much funding has EMRIS Pharma raised over time?

    EMRIS Pharma has raised $422K.

  • Who are EMRIS Pharma’s investors?

    MassChallenge, Arieli Group, Innovation Authority, Hadasit, and NGT HealthCare II have invested in EMRIS Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process